Peripartum Cardiomyopathy, Postpartum

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Peripartum Cardiomyopathy, Postpartum trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 4

NCT05180773

Impact of Bromocriptine on Clinical Outcomes for Peripartum Cardiomyopathy

The study will enroll 200 women newly diagnosed with peripartum cardiomyopathy within 5 months postpartum in a randomized placebo controlled trial of bromocript…

United States250 participantsStarted 2022-07-27

Treatment: Bromocriptine, Placebo

All recent trials (2 shown)

CompletedNot Applicable

NCT01085955

Investigation in Pregnancy Associate Cardiomyopathy

Peri-partum cardiomyopathy is a heart muscle weakness that occurs during or following pregnancy. Research suggests that many initial heart injuries including vi…

United States100 participantsStarted 2009-10